Crescita Therapeutics (TSE:CTX) Stock Price Up 5.4% – What’s Next?

Crescita Therapeutics Inc. (TSE:CTX) shares traded up 5.4% during mid-day trading on Monday . The company traded as high as C$0.60 and last traded at C$0.59. 20,875 shares were traded during mid-day trading, an increase of 102% from the average session volume of 10,325 shares. The stock had previously closed at C$0.56.

Crescita Therapeutics Stock Down 1.7 %

The business has a fifty day moving average of C$0.56 and a 200 day moving average of C$0.58. The stock has a market capitalization of C$10.68 million, a price-to-earnings ratio of -3.94 and a beta of 1.69. The company has a debt-to-equity ratio of 5.77, a current ratio of 2.70 and a quick ratio of 2.29.

Insider Activity

In related news, Director Jose Darocha acquired 86,000 shares of the firm’s stock in a transaction on Friday, December 27th. The stock was bought at an average price of C$0.60 per share, for a total transaction of C$51,436.60. Insiders own 10.87% of the company’s stock.

About Crescita Therapeutics

Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.